4//SEC Filing
Mueller Brian 4
Accession 0001048477-24-000028
CIK 0001048477other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:18 PM ET
Size
9.0 KB
Accession
0001048477-24-000028
Insider Transaction Report
Form 4
Mueller Brian
VP, Corporate Controller
Transactions
- Award
Common Stock
2024-02-27+20,220→ 66,343 total - Award
Common Stock
2024-02-27+6,103→ 81,248 total - Award
Common Stock
2024-02-27+8,802→ 75,145 total
Footnotes (5)
- [F1]Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.
- [F2]Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.
- [F3]Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.
- [F4]Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.
- [F5]Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001514980
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:18 PM ET
- Size
- 9.0 KB